Tango Therapeutics, Inc. (TNGX)
21.63
+0.41
(+1.93%)
USD |
NASDAQ |
Apr 02, 16:00
22.00
+0.37
(+1.71%)
After-Hours: 20:00
Tango Therapeutics EPS Diluted (Quarterly) : -0.2945 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.855 |
| Kodiak Sciences, Inc. | -1.042 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| AbbVie, Inc. | 1.018 |
| Teleflex, Inc. | -16.15 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.75M |
| Total Expenses (Quarterly) | 38.75M |
| Enterprise Value | 2.776B |
| Earnings Yield | -3.92% |
| Normalized Earnings Yield | -3.920 |